Form D — Cure Ventures Fund II, L.P.
0002094337-25-000001 · filed Dec 18, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pooled Investment Fund filings
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- Rule 506(b), Investment Company Act Section 3(c), Investment Company Act Section 3(c)(1), Investment Company Act Section 3(c)(7)
- Reported offering amount
- —
- Reported amount sold
- $0
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Cure Ventures Fund II, L.P.
- CIK
- 2094337
- Entity
- Limited Partnership
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 349 NEWBURY STREET
BOSTON, Massachusetts 02115 - Phone
- 970-759-6000
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
N/A Cure Ventures Fund II GP, LLC · Executive OfficerBOSTON, Massachusetts Find on LinkedIn ↗
-
David Fallace · Executive OfficerBOSTON, Massachusetts Find on LinkedIn ↗
-
Richard Lim · Executive OfficerBOSTON, Massachusetts Find on LinkedIn ↗
-
Louis Tartaglia · Executive OfficerBOSTON, Massachusetts Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗